Edison Investment Research is terminating coverage on Codere (CDR), Fidelity Asian Values (FAS), Fidelity China Special Situations (FCSS), Fidelity European Trust (FEV), Fidelity Japan Trust (FJV), Fidelity Special Values (FSV), Orège (OREGE) and Silence Therapeutics (SLN). Please note you should no longer rely on any previous research or estimates for these companies. All forecasts should now be considered redundant.
Companies: Silence Therapeutics plc
Companies: BXPHAR SLN IXI REDX
Companies: Cambridge Cognition Holdings Plc (COG:LON)Silence Therapeutics plc (SLN:LON)
Cellular Goods a UK-based provider of premium consumer products based on biosynthetic cannabinoids announced its intention to join the main market (standard) this spring. Target valuation £20m raising c. £8m “to finalise the development and launch of a range of the Company's premium-quality consumer products based on biosynthetic cannabinoids, which is fully compliant under UK law.” Kanabo Group (RTO by Spinnaker Opportunities SOP.L) on the main market (standard). Raising £6m, enlarged mkt cap £
Companies: KIBO HSP MIL SAVE AQX DFCH TEK AST SLN WHR
Upon Admission to AIM, Nightcap will acquire The London Cocktail Club Limited (the "London Cocktail Club"), which is an award winning independent operator of ten individually themed cocktail bars in nine London locations and one location in Bristol. Offer TBC Due mid Jan.
HSS Hire Group, HSS.L transfer from Main to Aim. Mkt Cap c. £70m. Recently raised £52.6m. Leading supplier of tool and equipment for hire in the United Kingdom and Ireland and has provided equipment hire services in the Unit
Companies: CCS SEE ROCK PGH SWG SLN ORPH EQLS TEK AVO
Silence provided a corporate update with its H120 financial results that show it moving forward on all fronts. It announced that it has hired a new CEO, listed its stock on Nasdaq, enrolled its first volunteers in SLN124’s Phase I study, filed its SLN360 IND ahead of schedule and expanded its existing partnership with Mallinckrodt, all in the past few weeks.
Companies: GILD SLN N4P
N4 Pharma (N4P.L): COVID-19 research project update | Silence Therapeutics (SLN.L): Half-year results
Companies: N4 Pharma Plc (N4P:LON)Silence Therapeutics plc (SLN:LON)
Synairgen (SNG.L): Positive interim data from trial of SNG001 in COPD patients | Silence Therapeutics (SLN.L): R&D Update | Verona Pharma plc (AIM: VRP.L): Initation of pilot study in COVID-19 patients
Companies: SNG SLN VRNA
Silence Therapeutics (SLN.L): Mallinckrodt exercise option to license two assets
Beximco Pharma (BXP.L): Third quarter results for 2020 | Silence Therapeutics (SLN.L): Business update
Companies: Beximco Pharmaceuticals Limited (BXPHARMA:DHA)Silence Therapeutics plc (SLN:LON)
Research Tree provides access to ongoing research coverage, media content and regulatory news on Silence Therapeutics plc.
We currently have 59 research reports from 5
i(x) Net Zero, the investing company which focusses on Energy Transition and Sustainability in the Built Environment, announces its intention to join AIM. Following Admission, the Company intends to use the net proceeds of the proposed Fundraising to provide development and expansion capital to certain of its investee companies, for future investments in companies that fall primarily within its areas of interest in Energy Transition and Sustainability in the Built Environment and to provide work
Companies: TGN AFC COIN COIN HL/ OMI
Tern plc* (TERN.L, 14.35p/£50.5m) Portfolio update: Strategic investment for Device Authority from global player (02.12.21) | Mirada plc* (MIRA.L, 74p/£6.6m) Interims: Return to growth; expansion of sales pipeline (02.12.21) | Blackbird plc* (BIRD.L, 28.75p/£96.9m) Update: Additional US TV stations secured (03.12.21) | Mobile Tornado plc* (MBT.L, 1.875p/£7.1m) Update: Notice from customer (01.12.21)
Companies: TERN MIRA BIRD MBT
No Joiners Today.
No Leavers Today.
What’s cooking in the IPO kitchen?
Public Policy Holding Company, to join AIM. PPHC, through its wholly-owned companies, operates a portfolio of independent firms that offer public affairs, crisis management, lobbying and advocacy services on behalf of corporate, trade association and non-profit client organisations. Mkt Cap and Capital to be raised TBC. Expected admission date Mid Dec.
Libertine to join AIM. Libertine has developed a technolog
Companies: TRAK GAMA AAZ FNTL DPP
Friday's market sell off saw some violent downward moves in many stocks with little initial differentiation between sectors or the key drivers of businesses, creating significant share price drops in a number of higher quality or uncorrelated names. We take a look at some stocks we believe have either seen an unwarranted sell-off, have seen weakness go under the radar or where there is now a more attractive opportunity.
Companies: ANX IBPO CYAN SOM EQT AFM
Water Intelligence has announced the reacquisition of its South Oregon franchise for $1.38m, delivering quickly on its proposed reacquisition strategy outlined in last months oversubscribed £12.5m fundraising. The consideration equates to 1.2x FY21 revenue and 5.5x PBT and will be paid over the next 12 months and is highly accretive. We view the acquisition as attractive and strategically the acquisition fits well with the January reacquisition of Seattle, also in the Northwest USA. We make no c
Companies: Water Intelligence plc
No joiners today
No leavers today
What’s cooking in the IPO kitchen?
Trinistar Liverpool S.a r.L announces its potential listing of a newly formed single asset company which will own the Capital Building in Liverpool on the IPSX. Upon admission the Company would become a real estate investment trust (REIT). The Capital Building occupies close to a 3.5 acre freehold site in the centre of Liverpool’s business district; the building comprises c425,000 square feet of predominantly of
Companies: ADBE ADBE SYM ARC AVCT CMCL CLIN DCTA FRAN OSI
Atlantic Lithium* (ALL LN) formerly IronRidge* (IRR LN) – Scoping study update increases post-tax NPV to US$789m for Ewoyaa
Bluejay Mining* (JAY LN) – Dundas bulk samples sent for customer evaluation
Cornish Metals* (CUSN LN) –– Drilling at United Downs continues to intersect multiple mineralised structures
Eurasia Mining* (EUA LN) – Agreement with ERDC
Gemfields (GEM LN) – Record Kagem emerald auction
Hummingbird Resources (HUM LN) – Pasofino raises $5.5m to deliver Dugbe FS in Q2/22
Companies: CUSN GML JAY EUA HUM SHG TYM MTR ALL
ValiRx is a life sciences company which accelerates the development of treatments in oncology and women's health. The company is reaching a significant strategy inflection point as it continues implementation of its “connected innovation” strategy. It has signed a letter of intent to out-license VAL201, demonstrating good progress has been made to generate value from its legacy assets and move towards consolidating ValiRx' position as a key player in oncology and women's health. We initiate with
Companies: ValiRx PLC
Outstanding performance, in our view, disclosed by the UK-based FinTech on the occasion of its first earnings presentation. The top line, which had already been disclosed in mid-October was of no surprise however, the full financial statements have been provided, yielding a strong feeling of optimism and satisfaction regarding the business model’s advancement. The firm used this opportunity to raise its top-line guidance from mid-20s to mid-to-high 20s.
Companies: Wise PLC Class A
Companies: Mind Gym Plc
Today's news & views, plus announcements from BGK, SSPG, SUR, INCE, RQIH & GHS.
Companies: SUR RQIH INCE
Time to start looking ahead
Companies: Johnson Service Group PLC
FY2019 results are in line with the January 2019 update, save for following the disposal of Technical after the period, the results are shown on a continuing basis. Revenues rose 14% to £117.9m, underlying operating profit rose 25% to £9.1m and underlying PBT rose 29% to £8.9m. A final dividend of 10p has been proposed, making an unchanged 15p payout. We have set out initial ‘headline’ PBT estimates for FY2020E. We aim to publish a full note in due course, reflecting the recent corporate develop
Companies: Braemar Shipping Services plc
Today’s update reconfirms the integration of Memery Crystal is well underway, with the wider group on track to meet forecasts, upgraded at the time of deal completion (FY21 SCMe: Revs £45.5m, Adj. EBITDA £12.6m). As was originally communicated, Memery Crystal (“MC”) will sit alongside Rosenblatt (“RBL”) within the Group’s new legal services entity RBG Legal Services Ltd (“RBGLS”); it will, however, maintain its separate brand identity to capitalise on market positioning. All support functions, i
Companies: RBG Holdings Plc
RBG’s interims offer no surprises, with performance strong across all divisions and progress on track against our FY21e forecasts (Revs: £45.5m, Adj. EBITDA: £11.8m). The Group’s diversified revenue model has proved resilient against a continued backdrop of uncertainty – driving revenues +53% YoY against a somewhat weak comparative, split +35% organic, +18% from Memery Crystal (despite only one month of contribution). Demand for services across all three businesses remains strong, and management